Research programme: valproic acid analogue - Jazz Pharmaceuticals
Latest Information Update: 20 Aug 2010
At a glance
- Originator Jazz Pharmaceuticals
- Mechanism of Action GABA uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Bipolar disorders; Epilepsy
Most Recent Events
- 20 Aug 2010 Discontinued for Epilepsy in USA (unspecified route)
- 20 Aug 2010 Discontinued for Bipolar disorders in USA (unspecified route)
- 25 Mar 2008 Early research in Bipolar disorders in USA (unspecified route)